Stock PRME PRIME MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Prime Medicine, Inc.

Equities

PRME

US74168J1016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
6.48 USD -0.31% Intraday chart for Prime Medicine, Inc. -6.43% -26.86%
May. 20 HC Wainwright Starts Coverage on Prime Medicine With Buy Rating, $10 Price Target MT
May. 17 North American Morning Briefing : The "Everything -2- DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Prime Medicine to Present at Upcoming Investor Conferences
GL
Prime Medicine to Present at Upcoming Investor Conferences
AQ
Prime medicine reports first quarter 2024 financial results and provides business updates
AQ
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
GL
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
GL
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
GL
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
AQ
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
GL
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
GL
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
GL
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
AQ
Prime medicine reports full year 2023 financial results and provides business updates
AQ
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
GL
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
AQ
Prime Medicine to Participate in Upcoming Investor Conferences
GL
Prime Medicine to Participate in Upcoming Investor Conferences
AQ
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
GL
Prime Medicine Announces Pricing of Upsized Public Offering
GL
Prime Medicine Announces Proposed Public Offering of Common Stock
GL
Prime Medicine Announces Proposed Public Offering of Common Stock
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRME Stock
  4. News Prime Medicine, Inc.
  5. Press Releases